INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Aquestive Therapeutics, Inc. (Beta Bionics) due to significant stock losses and possible misleading statements made by the company [2][3]. Company Investigation - The investigation centers on whether Beta Bionics issued misleading statements or failed to disclose important information to investors [3]. - Following the announcement of fewer patient starts than analysts estimated for the fourth quarter, Beta Bionics' shares dropped approximately 37% on January 9, 2026 [3]. Legal Options for Investors - Investors who suffered significant losses in Beta Bionics stock or options are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [1][4].